High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Author:
Bolland WilliamORCID, Michel Vincent, Planas Delphine, Hubert Mathieu, Guivel-Benhassine Florence, Porrot Françoise, Staropoli Isabelle, N’Debi Mélissa, Rodriguez Christophe, Fourati SlimORCID, Prot Matthieu, Planchais Cyril, Hocqueloux Laurent, Simon-Lorière EtienneORCID, Mouquet Hugo, Prazuck Thierry, Pawlotsky Jean-MichelORCID, Bruel TimothéeORCID, Schwartz OlivierORCID, Buchrieser Julian
Abstract
ABSTRACTSARS-CoV-2 variants with undetermined properties have emerged intermittently throughout the COVID-19 pandemic. Some variants possess unique phenotypes and mutations which allow further characterization of viral evolution and spike functions. Around 1100 cases of the B.1.640.1 variant were reported in Africa and Europe between 2021 and 2022, before the expansion of Omicron. Here, we analyzed the biological properties of a B.1.640.1 isolate and its spike. Compared to the ancestral spike, B.1.640.1 carried 14 amino acid substitutions and deletions. B.1.640.1 escaped binding by some anti-NTD and -RBD monoclonal antibodies, and neutralization by sera from convalescent and vaccinated individuals. In cell lines, infection generated large syncytia and a high cytopathic effect. In primary airway cells, B.1.640.1 replicated less than Omicron BA.1 and triggered more syncytia and cell death than other variants. The B.1.640.1 spike was highly fusogenic when expressed alone. This was mediated by two poorly characterized and infrequent mutations located in the spike S2 domain, T859N and D936H. Altogether, our results highlight the cytopathy of a hyper-fusogenic SARS-CoV-2 variant, supplanted upon the emergence of Omicron BA.1.ImportanceOur results highlight the plasticity of SARS-CoV-2 spike to generate highly fusogenic and cytopathic strains with the causative mutations being uncharacterized in previous variants. We describe mechanisms regulating the formation of syncytia and the subsequent consequences in cell lines and a primary culture model, which are poorly understood.
Publisher
Cold Spring Harbor Laboratory
Reference70 articles.
1. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic 2. SARS-CoV-2 variants, spike mutations and immune escape 3. Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies 4. Bruel T , Stéfic K , Nguyen Y , Toniutti D , Staropoli I , Porrot F , Guivel-Benhassine F , Bolland WH , Planas D , Hadjadj J , Handala L , Planchais C , Prot M , Simon-Lorière E , André E , Baele G , Cuypers L , Mouthon L , Mouquet H , Buchrieser J , Sève A , Prazuck T , Maes P , Terrier B , Hocqueloux L , Schwartz O . 2022. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies. Cell Rep Med 3. 5. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway;Nat Microbiol,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|